Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Damoiseaux

Showing results (71-80 of 162) with videos related to

Pageof 17
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 19, 2013
A new series of small molecular weight compounds induce read through of all three types of nonsense mutations in the ATM geneLiutao Du, Michael E Jung, Robert Damoiseaux, et al.
Small (Weinheim an Der Bergstrasse, Germany)|October 29, 2018
A Gelatin Microdroplet Platform for High-Throughput Sorting of Hyperproducing Single-Cell-Derived Microalgal ClonesMing Li, Mark van Zee, Carson T Riche, et al.
NPJ Drug Discovery|May 5, 2025
Discovery of a small molecule secreted clusterin enhancer that improves memory in Alzheimer's disease miceWhitaker Cohn, Jesus Campagna, Dongwook Wi, et al.
Cancer Discovery|September 20, 2017
Exploiting Drug Addiction Mechanisms to Select against MAPKi-Resistant MelanomaAayoung Hong, Gatien Moriceau, Lu Sun, et al.
Cancer Discovery|July 1, 2024
Expression of Concern: Exploiting Drug Addiction Mechanisms to Select against MAPKi-Resistant MelanomaAayoung Hong, Gatien Moriceau, Lu Sun, et al.
Oncotarget|December 22, 2017
Microtubins: a novel class of small synthetic microtubule targeting drugs that inhibit cancer cell proliferationSilvia Senese, Yu-Chen Lo, Ankur A Gholkar, et al.
Plos Pathogens|August 1, 2014
Cytolethal distending toxins require components of the ER-associated degradation pathway for host cell entryAria Eshraghi, Shandee D Dixon, Batcha Tamilselvam, et al.
Cancer & Metabolism|July 11, 2018
A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancersShili Xu, Arthur Catapang, Daniel Braas, et al.
ACS Nano|January 2, 2010
Use of a rapid cytotoxicity screening approach to engineer a safer zinc oxide nanoparticle through iron dopingSaji George, Suman Pokhrel, Tian Xia, et al.
ACS Synthetic Biology|January 5, 2017
Engineering a Thermostable Keto Acid Decarboxylase Using Directed Evolution and Computationally Directed Protein DesignLemuel M J Soh, Wai Shun Mak, Paul P Lin, et al.
Pageof 17

Showing results (71-80 of 162) with videos related to

Sort By:
Pageof 17
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 19, 2013
A new series of small molecular weight compounds induce read through of all three types of nonsense mutations in the ATM geneLiutao Du, Michael E Jung, Robert Damoiseaux, et al.
Small (Weinheim an Der Bergstrasse, Germany)|October 29, 2018
A Gelatin Microdroplet Platform for High-Throughput Sorting of Hyperproducing Single-Cell-Derived Microalgal ClonesMing Li, Mark van Zee, Carson T Riche, et al.
NPJ Drug Discovery|May 5, 2025
Discovery of a small molecule secreted clusterin enhancer that improves memory in Alzheimer's disease miceWhitaker Cohn, Jesus Campagna, Dongwook Wi, et al.
Cancer Discovery|September 20, 2017
Exploiting Drug Addiction Mechanisms to Select against MAPKi-Resistant MelanomaAayoung Hong, Gatien Moriceau, Lu Sun, et al.
Cancer Discovery|July 1, 2024
Expression of Concern: Exploiting Drug Addiction Mechanisms to Select against MAPKi-Resistant MelanomaAayoung Hong, Gatien Moriceau, Lu Sun, et al.
Oncotarget|December 22, 2017
Microtubins: a novel class of small synthetic microtubule targeting drugs that inhibit cancer cell proliferationSilvia Senese, Yu-Chen Lo, Ankur A Gholkar, et al.
Plos Pathogens|August 1, 2014
Cytolethal distending toxins require components of the ER-associated degradation pathway for host cell entryAria Eshraghi, Shandee D Dixon, Batcha Tamilselvam, et al.
Cancer & Metabolism|July 11, 2018
A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancersShili Xu, Arthur Catapang, Daniel Braas, et al.
ACS Nano|January 2, 2010
Use of a rapid cytotoxicity screening approach to engineer a safer zinc oxide nanoparticle through iron dopingSaji George, Suman Pokhrel, Tian Xia, et al.
ACS Synthetic Biology|January 5, 2017
Engineering a Thermostable Keto Acid Decarboxylase Using Directed Evolution and Computationally Directed Protein DesignLemuel M J Soh, Wai Shun Mak, Paul P Lin, et al.
Pageof 17